Skip to main content

Advertisement

Log in

Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the early efficacy and safety of intrastromal injection of teicoplanin as the alternative treatment for the methicillin-resistant Staphylococcus aureus (MRSA) keratitis by comparing it with vancomycin.

Materials and methods

Twenty-four eyes of 24 New Zealand white rabbits were included in the study. MRSA keratitis was induced in the right eye of each rabbit by injecting 0.1 mL MRSA suspension containing 1000 colony-forming units (CFU) intrastromally to the central cornea. The rabbits were divided into three treatment groups 24 h after the inoculation of MRSA. Eight rabbits received intrastromal teicoplanin therapy, eight received intrastromal vancomycin therapy, and eight received balanced salt solution and served as the control group. Nine hours after the treatment, all rabbits were sacrificed and corneal tissues were collected for microbiological analysis. We also examined and scored all the rabbits clinically before and after the treatment.

Results

The control group scored higher with regard to conjunctival injection, iritis, fibrin, hypopyon, epithelial erosion, and corneal infiltrate than the vancomycin and teicoplanin groups (p = 0.031, 0.010, < 0.001, 0.029, 0.009, and < 0.001, respectively). Chemosis and corneal oedema were similar in all groups (p = 0.731 and 0.075, respectively). The severity of all clinical parameters was similar in both the vancomycin and teicoplanin groups after the treatment. The bacterial load was the highest (7.83 ± 0.71 log10 CFU/g) in the control group. The eyes treated with vancomycin and teicoplanin had similar bacterial loads (6.40 ± 0.69 vs. 6.31 ± 0.75 log10 CFU/g, p = 0.809).

Conclusion

The efficiency of teicoplanin seems to be comparable to that of vancomycin when administered intrastromally in the early treatment of MRSA keratitis. The former may be preferred in the treatment of selected cases with vancomycin hypersensitivity or resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Availability of data and materials

Not applicable.

References

  1. Egrilmez S, Yildirim-Theveny S (2020) Treatment-resistant bacterial keratitis: challenges and solutions. Clin Ophthalmol 14:287–297

    Article  CAS  Google Scholar 

  2. Durrani AF, Atta S, Bhat A et al (2020) Methicillin-resistant Staphylococcal aureus keratitis: initial treatment, risk factors, clinical features, and treatment outcomes. Am J Ophthalmol 214:119–126

    Article  CAS  Google Scholar 

  3. Robaei D, Carnt N, Watson S (2016) Established and emerging ancillary techniques in management of microbial keratitis: a review. Br J Ophthalmol 100(9):1163–1170

    Article  Google Scholar 

  4. Romanowski EG, Romanowski JE, Shanks RMQ et al (2020) Topical vancomycin 5% is more efficacious than 2.5% and 1.25% for reducing viable methicillin-resistant staphylococcus aureus in infectious keratitis. Cornea 39(2):250–253

    Article  Google Scholar 

  5. Flynn HW, Batra NR, Schwartz SG, Grzybowski A. (2018) Antimicrobial treatment: routes/dosages/preparation/adverse effects, antimicrobial resistance, and alternatives. Endophthalmitis in clinical practice, Springer, pp 123–139

  6. Ong SJ, Huang YC, Tan HY et al (2013) Staphylococcus aureus keratitis: a review of hospital cases. PLoS ONE 8(11):e80119

    Article  CAS  Google Scholar 

  7. Cong Y, Yang S, Rao X (2020) Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res 21:169–176

    Article  Google Scholar 

  8. Liu CY, Lee WS, Fung CP et al (1996) Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant staphylococcus aureus bacteraemia. Clin Drug Investig 12(2):80–87

    Article  CAS  Google Scholar 

  9. Svetitsky S, Leibovici L, Paul M (2009) Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 53(10):4069–4079

    Article  CAS  Google Scholar 

  10. Torumkuney D, Tunger A, Sancak B et al (2020) Results from the Survey of antibiotic resistance (SOAR) 2015–17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. J Antimicrob Chemother 75(Supplement_1):i88–i99

    Article  CAS  Google Scholar 

  11. Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T (1996) Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 83(10):1345–1349

    Article  CAS  Google Scholar 

  12. Mengeloglu FZ, Kucukbayrak A, Bucak YY et al (2013) Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits. J Ocul Pharmacol Ther 29(10):893–899

    Article  CAS  Google Scholar 

  13. Akova Budak B, Baykara M, Kivanc SA, Yilmaz H, Cicek S (2016) Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis. Cutan Ocul Toxicol 35(2):126–130

    CAS  PubMed  Google Scholar 

  14. Goktas S, Kurtoglu MG, Sakarya Y et al (2015) New therapy option for treatment of methicillin-resistant Staphylococcus aureus keratitis: tigecycline. J Ocul Pharmacol Ther 31(2):122–127

    Article  CAS  Google Scholar 

  15. Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM (2010) An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(8):4151–4155

    Article  Google Scholar 

  16. Kaye SB, Neal T, Nicholson S et al (2009) Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea. Invest Ophthalmol Vis Sci 50(7):3176–3184

    Article  Google Scholar 

  17. Briggs MC, McDonald P, Bourke R, Smith G, McGalliard JN, Wong D (1998) Intravitreal penetration of teicoplanin. Eye (Lond) 12(Pt 2):252–255

    Article  Google Scholar 

  18. Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H (2012) Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 250(4):499–505

    Article  CAS  Google Scholar 

  19. Gupta AA, Mammo DA, Page MA (2020) Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review. Graefes Arch Clin Exp Ophthalmol 258(1):167–173

    Article  CAS  Google Scholar 

  20. Nada WM, Al Aswad MA, El-Haig WM (2017) Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study. Clin Ophthalmol 11:871–874

    Article  CAS  Google Scholar 

  21. Liang SY, Lee GA (2011) Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis. J Cataract Refract Surg 37(5):960–962

    Article  Google Scholar 

  22. Feng HL, Robbins CB, Fekrat S (2020) A nine-year analysis of practice patterns, microbiologic yield, and clinical outcomes in cases of presumed infectious endophthalmitis. Ophthalmol Retina 4(6):555–559

    Article  Google Scholar 

  23. Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ (2003) In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob Agents Chemother 47(7):2334–2338

    Article  CAS  Google Scholar 

  24. Fleischer AB, Hoover DL, Khan JA, Parisi JT, Burns RP (1986) Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjunctivitis. Am J Ophthalmol 101(3):283–287

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

AYU and MB designed and conducted the study. MB made substantial contributions to acquisition of microbiological data. AYU wrote the manuscript. Two authors read and approved the final manuscript.

Corresponding author

Correspondence to Ahmet Yucel Ucgul.

Ethics declarations

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethical approval

The Animal Experiments Local Ethics Committee at the University of Abant Izzet Baysal (Bolu, Turkey) approved the study (Approval No: 2019/41).

Plant reproducibility

Not applicable.

Clinical trials registration

None.

Gels and blots/image manipulation

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ucgul, A.Y., Behcet, M. Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis. Int Ophthalmol 41, 1395–1402 (2021). https://doi.org/10.1007/s10792-021-01696-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-021-01696-2

Keywords

Navigation